Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges

The incidence and case-fatality rates (CFRs) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, the etiological agent for Coronavirus Disease 2019 (COVID-19), have been rising unabated. Even though the entire world has been implementing infection prevention and control measur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Vaccin Immunother
Main Authors: Abdullahi, Idris Nasir, Emeribe, Anthony Uchenna, Adekola, Hafeez Aderinsayo, Abubakar, Sharafudeen Dahiru, Dangana, Amos, Shuwa, Halima Ali, Nwoba, Sunday Theophilus, Mustapha, Jelili Olaide, Haruna, Muyideen Titilope, Olowookere, Kafayat Adepeju, Animasaun, Olawale Sunday, Ugwu, Charles Egede, Onoja, Solomon Oloche, Gadama, Abdullahi Sani, Mohammed, Musa, Daneji, Isa Muhammad, Amadu, Dele Ohinoyi, Ghamba, Peter Elisha, Onukegbe, Nkechi Blessing, Shehu, Muhammad Sagir, Isomah, Chiladi, Babayo, Adamu, Ahmad, Abdurrahman El-Fulaty
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7993231/
https://ncbi.nlm.nih.gov/pubmed/32936732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1812313
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados